Почетна › Склеродерма › Тексас
Kliničke studije za Склеродерма u državi Тексас
12 studija za Склеродерма traži učesnike na lokacijama u državi Тексас.
Gradovi u državi Тексас
Zvanični tekst studije (na engleskom)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- и још 2
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03816345Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06434363A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Dallas
Тражи се учесникФаза 1/2
Узраст од 18 до 75 · Оба пола · Ажурирано 30. 10. 2026. · NCT06733935A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Tekton Research, Inc - West Gate Boulevard, Austin
- Arthritis & Rheumatology Institute - Frisco, Frisco
- The University of Texas Health Science Center at Houston, Houston
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT07497087A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Denison
- GSK Investigational Site, El Paso
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 8. 9. 2026. · NCT05878717Platform Clinical Study for Conquering Scleroderma
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT06195072AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Arlington, Arlington
- Artiva Investigational Site Bellaire, Bellaire
- Artiva Investigational Site Irving, Irving
- и још 4
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 31. 7. 2026. · NCT06991114A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
- The University of Texas Health Science Center at Houston, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 8. 7. 2026. · NCT06827977Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
- UT Southwestern Medical Center - Department of Dermatology, Dallas
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
До 90 година · Оба пола · Ажурирано 12. 5. 2026. · NCT01808937A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
- Galderma Investigational Site#7096, Arlington
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 31. 3. 2026. · NCT07047690Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
- The University of Texas Health Science Center at Houston, Houston
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 26. 6. 2025. · NCT05989763Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Dallas
- aTyr Investigative Site, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 7. 5. 2025. · NCT05892614Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.